Minireviews
Copyright ©The Author(s) 2024.
World J Stem Cells. Feb 26, 2024; 16(2): 102-113
Published online Feb 26, 2024. doi: 10.4252/wjsc.v16.i2.102
Figure 2
Figure 2 Schematic illustration of small molecule compounds inducing the osteogenic differentiation of mesenchymal stem cells. Small molecule compounds stimulate the bone morphogenetic protein signaling pathway and promote β-catenin accumulation. Then, β-catenin migrates to the nucleus and forms a β-catenin-T-cell factor/lymphoid enhancer-binding factor complex to initiate the transcription of genes associated with osteogenesis. GSK-3β: Glycogen synthase kinase 3 beta; APC: Adenomatosis polyposis coli; CK1-α: Casein kinase 1α; DSH: Disheveled; TCF/LEF: T-cell factor/lymphoid enhancer-binding factor; DKK1: Dickkopf 1; LRP5/6: Lipoprotein receptor-related proteins 5 or 6; BMP: Bone morphogenetic protein.